Pecoraro, C.; Parrino, B.; Cascioferro, S.; Puerta, A.; Avan, A.; Peters, G.J.; Diana, P.; Giovannetti, E.; Carbone, D.
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules 2022, 27, 19.
https://doi.org/10.3390/molecules27010019
AMA Style
Pecoraro C, Parrino B, Cascioferro S, Puerta A, Avan A, Peters GJ, Diana P, Giovannetti E, Carbone D.
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules. 2022; 27(1):19.
https://doi.org/10.3390/molecules27010019
Chicago/Turabian Style
Pecoraro, Camilla, Barbara Parrino, Stella Cascioferro, Adrian Puerta, Amir Avan, Godefridus J. Peters, Patrizia Diana, Elisa Giovannetti, and Daniela Carbone.
2022. "A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells" Molecules 27, no. 1: 19.
https://doi.org/10.3390/molecules27010019
APA Style
Pecoraro, C., Parrino, B., Cascioferro, S., Puerta, A., Avan, A., Peters, G. J., Diana, P., Giovannetti, E., & Carbone, D.
(2022). A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules, 27(1), 19.
https://doi.org/10.3390/molecules27010019
